A Canadian biotechnology company has filed a $250 million lawsuit against a well-known Wall Street commentary site over coverage by reporter Adam Feuerstein. “To put that number in context, it’s roughly twice Generex’s market cap.” [Felix Salmon, Reuters]
Comments are closed.